Business
Leveljump Record Revenues; Q2 Revenue increase of 42%; Q2 Adjusted EBITDA of $0.005 per share
Toronto, Ontario--(Newsfile Corp. - August 18, 2022) - LevelJump Healthcare Corp. (TSXV: JUMP)...
About this update from Leveljump Healthcare Corp.
[{"type":"text","content":"Leveljump Record Revenues; Q2 Revenue increase of 42%; Q2 Adjusted EBITDA of $0.005 per shareToronto, Ontario--(Newsfile Corp. - August 18, 2022) - LevelJump Healthcare Corp. (TSXV: JUMP) (OTCQB: JMPHF) (FSE: 75J) (\"LevelJump\" or the \"Company\"), a Canadian leader in B2B telehealth solutions, is pleased to announce today it has reported financial results for the second fiscal quarter ended June 30, 2022. All amounts are expressed in Canadian dollars.Financial and Operational HighlightsQ2 Adjusted EBITDA of $0.005 per share.Annual run rate is now over $10 million, with investments in associates is now over $13 million.Revenues from Canadian Teleradiology Services, Inc. (\"CTS\") operations hits record level with $2,335,794 in revenues for the second quarter.Gross profit from CTS operations was $664,745 for the quarter, a 29% margin;Year over Year Q2 revenue increase of $695,881 an increase of 42%.Financial GuidanceManagement is currently estimating adjusted EBITDA of between $0.01 to $0.015 per share for Fiscal Year 2022.Management Comments\"We had another record quarter of revenue with positive adjusted EBITDA,\" repeated Mitch Geisler CEO, from his Q1 2022 comments. \"This makes two consecutive quarters of positive adjusted EBITDA, and we are rapidly growing and working on additional acquisitions with a goal to hit over $20 million in annual run rate before the end of 2023 and increase adjusted EBITDA to $0.02 to $0.04 per share in 2023, along with showing a positive net earnings per share.\" Mitch added, \"we are one of the few Telehealth companies operating profitably and we expect to be able to expand our model rapidly.\"Non-GAAP Financial MeasuresThis news release contains financial terms (such as adjusted EBITDA) that are not considered under GAAP. Such financial measures, together with measures prepared in accordance with GAAP, provide useful information to investors and shareholders, as management uses them to evaluate the operating performance of the Company. The Company's determination of these non-GAAP measures may differ from other reporting issuers, and therefore are unlikely to be comparable to similar measures presented by other companies. Further, these non-GAAP measures should not be considered in isolation or as a substitute for measures of performance or cash flows prepared in accordance with GAAP. These fi...